Phase II study of irinotecan (CPT-11) administered every 2 weeks as treatment for patients with colorectal cancer resistant to previous treatment with 5-fluorouracil-based therapies: comparison of two different dose schedules (250 and 200 mg/m2) acc (Q45085126)
Jump to navigation
Jump to search
scientific article published in October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of irinotecan (CPT-11) administered every 2 weeks as treatment for patients with colorectal cancer resistant to previous treatment with 5-fluorouracil-based therapies: comparison of two different dose schedules (250 and 200 mg/m2) acc |
scientific article published in October 2004 |
Statements
1 reference
Phase II study of irinotecan (CPT-11) administered every 2 weeks as treatment for patients with colorectal cancer resistant to previous treatment with 5-fluorouracil-based therapies: comparison of two different dose schedules (250 and 200 mg/m2) acc (English)
1 reference
Eugeni Saigi
1 reference
Antonieta Salut
1 reference
Juan Manuel Campos
1 reference
Ferran Losa
1 reference
Hermini Manzano
1 reference
Eduard Batiste-Alentorn
1 reference
Angels Acusa
1 reference
Edelmira Vélez de Mendizabal
1 reference
Inmaculada Guasch
1 reference
Isabel Antón
1 reference
ACROSS Cooperative Group
1 reference
1 October 2004
1 reference
1 reference
15
1 reference
9
1 reference
835-841
1 reference
Identifiers
1 reference
1 reference